Director at Indivior (INDV) receives 6,518 restricted stock units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Kingsley Stuart A reported acquisition or exercise transactions in this Form 4 filing.

Indivior Pharmaceuticals, Inc. director Stuart A. Kingsley received an equity award of 6,518 shares of common stock in the form of restricted stock units. These RSUs were granted at $0.00 per share as compensation, not through an open-market purchase.

Each RSU represents a right to receive one share of common stock and will vest on the day immediately before the next annual stockholder meeting following the grant date, if Kingsley continues serving the company. After this award, he holds 12,100 shares of Indivior common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kingsley Stuart A

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,518	$0.00	--

Holdings After Transaction: Common Stock — 12,100 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSU grant size: 6,518 shares Grant price: $0.00 per share Shares after transaction: 12,100 shares +1 more

4 metrics

RSU grant size 6,518 shares Restricted Stock Units granted to director on 2026-05-13

Grant price $0.00 per share Compensation award, not open-market purchase

Shares after transaction 12,100 shares Total common stock held directly following the RSU grant

Transaction code A Grant, award, or other acquisition of non-derivative common stock

Key Terms

Restricted Stock Units (RSUs), contingent right, vest, annual meeting of the Issuer's stockholders, +1 more

5 terms

Restricted Stock Units (RSUs) financial

"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's common stock."

vest financial

"The RSUs vest on the day immediately preceding the date of the annual meeting"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting of the Issuer's stockholders financial

"the date of the annual meeting of the Issuer's stockholders following the date of grant"

continued service financial

"subject to the Reporting Person's continued service to the Issuer on the vesting date."

Form 4 Insider Transactions: What Each Field Means →

05/14/2026 - 04:10 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kingsley Stuart A

(Last)

(First)

(Middle)

10710 MIDLOTHIAN TURNPIKE

SUITE 125

(Street)

NORTH CHESTERFIELD

VIRGINIA

23235

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Indivior Pharmaceuticals, Inc. [ INDV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/13/2026		A		6,518⁽¹⁾	A	$0	12,100	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Remarks:

	/s/Alice Givens, Power of Attorney	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Indivior (INDV) director Stuart A. Kingsley report in this Form 4?

Stuart A. Kingsley reported receiving 6,518 restricted stock units of Indivior common stock as a compensation award. These units were granted at no cash cost and increase his direct holdings to 12,100 shares following the transaction.

Is the Indivior (INDV) Form 4 transaction an open-market buy or a stock grant?

The transaction is a stock grant, not an open-market purchase. Kingsley received 6,518 restricted stock units as compensation, recorded with transaction code A for grant or award acquisition, at a price of $0.00 per share.

How many Indivior (INDV) shares does Stuart A. Kingsley hold after this grant?

Following the grant, Kingsley directly holds 12,100 shares of Indivior common stock. This total includes the 6,518 restricted stock units awarded in the reported transaction, assuming they ultimately vest and convert to shares.

When do Stuart A. Kingsley’s Indivior (INDV) RSUs vest?

The restricted stock units vest on the day immediately preceding the date of Indivior’s next annual meeting of stockholders after the grant. Vesting is contingent on Kingsley’s continued service to the company through that vesting date.

What does each RSU in the Indivior (INDV) grant represent?

Each restricted stock unit represents a contingent right to receive one share of Indivior common stock. The units convert into shares only if the vesting conditions are satisfied, including timing tied to the next annual meeting and continued service.